Collegium Pharmaceutical, Inc.

Collegium Pharmaceutical Misses on EPS, Stock Down 4.89%

Collegium Pharmaceutical reported a larger-than-expected loss in EPS, which contributed to a decline in the stock price by nearly 5%. The lack of revenue figures and management commentary leaves uncertainty about the company's performance and future direction. Investors may be cautious as they await more information.